IMGN - Sutro gains as Oppenheimer sees 200% upside on ADC potential
2023-10-06 12:20:23 ET
More on Sutro Biopharma
- Sutro BioPharma: Good Stewardship Through Early Trials
- Seeking Alpha’s Quant Rating on Sutro Biopharma
- Historical earnings data for Sutro Biopharma
- Financial information for Sutro Biopharma
For further details see:
Sutro gains as Oppenheimer sees 200% upside on ADC potential